✳flâneur — a map of the web's best reading
Remember That DNA You Gave 23andMe? - The Atlantic
theatlantic.com · 1,241 words · saved by 1 readers
The company is in trouble, and anyone who has spit into one of the company’s test tubes should be concerned.
Listen − 1.0 x + Seek 0:00 7:56 23andMe is not doing well . Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month, only the latest in several rounds of layoffs. Last week, the entire board of directors quit, save for Anne Wojcicki, a co-founder and the company’s CEO. Amid this downward spiral, Wojcicki has said she’ll consider selling 23andMe—which means the DNA of 23andMe’s 15 million customers would be up for sale, too. 23andMe’s trove of genetic data might be its most valuable asset. For about two decades now, since human-genome analysis bec
Explore this link on the map →related reading
- The 23andMe Deal - Cremieux Recueilcremieux.xyz
- Why don’t we screen healthy people to catch diseases early? | Out-Of-Pocketoutofpocket.health
- Biotech’s Lost Archive | IFPifp.org
- Startup Ideas · Gwern.netgwern.net
- How to Secure the DNA Supply Chain | IFPifp.org
- The sad state of personal data and infrastructure | beepb00pbeepb00p.xyz
- Nature's drug database - The Works in Progress Newsletterworksinprogress.news
- Putting Data in a Corner: LLMs and Financial Services Data | Andreessen Horowitza16z.com
- Biotech’s Lost Archive | IFPifp.org
- Monthly Roundup #40: March 2026 - by Zvi Mowshowitzthezvi.substack.com
- We caught Nevada sharing personal health data with Big Tech - The Nevada Independentthenevadaindependent.com
- Supporting Follow-Up Screening for Flagged Nucleic Acid Synthesis Orders - The Council on Strategic Riskscouncilonstrategicrisks.org